Skip to main content
. 2012 May 21;18(19):2390–2395. doi: 10.3748/wjg.v18.i19.2390

Table 2.

Subjective global symptom assessment n (%)

Better Same Worse Total
Group A 20 (71.4) 7 (25.0) 1 (3.6) 28
Group B 17 (65.4) 8 (30.8) 1 (3.8) 26
Total 37 15 2 54

P = 0.9; Group A, rabeprazole; Group B, ranitidine.